Deflectable Catheters - Market Insights, Competitive Landscape, and Market Forecast - 2030

Deflectable Catheters - Market Insights, Competitive Landscape, and Market Forecast - 2030

Deflectable Catheters By Product Type (Uni-Directional Deflectable Catheters, Bi-Directional Deflectable Catheters, And Multi-Directional Deflectable Catheters), Application (Cardiology [Electrophysiology, Coronary Interventions, And Diagnostic Imaging], Pulmonology [Pulmonary Angiography, And Bronchography]), End-User (Hospitals & Clinics, Ambulatory Surgical Centers, And Others), And Geography (North America, Europe, Asia-Pacific, And Rest Of The World) is expected to grow at a steady CAGR forecast till 2030 owing to the growing prevalence of cardiovascular and respiratory disorders along with the increasing demand for minimally invasive procedures

The deflectable catheters market is estimated to grow at a CAGR of 5.14% during the forecast period from 2024 to 2030. The demand for deflectable catheters is primarily being boosted by the increasing cases of chronic disorders such as cardiovascular diseases including heart attack, atrial fibrillation, coronary artery disease; respiratory disorders like asthma, chronic obstructive pulmonary disease COPD, among others. Additionally, the rising shift towards minimally invasive approaches among healthcare professionals and patients is also expected to drive the market for deflectable catheters during the forecast period from 2024 to 2030.

Deflectable Catheters Dynamics:

As per the recent data provided by the World Heart Report (2023), in 2021 it was stated that more than half a billion people were living with cardiovascular diseases globally.

Further according to recent data provided by the American Heart Association (2023), it estimated that by 2030 over 12 million people will have atrial fibrillation globally. Thus, as the incidence of cardiovascular diseases increase, there's a growing demand for advanced treatment options like deflectable catheters as they play a crucial role in the diagnosis and treatment of various cardiovascular conditions. These catheters are utilized in minimally invasive procedures such as cardiac ablation, angioplasty, and electrophysiology studies, allowing physicians to navigate complex cardiac anatomy with precision and control thereby boosting the market of deflectable catheters.

According to the data provided by WHO (2024), in 2019 that there were 262 million people affected by asthma. Additionally in 2023, there were 392 million people living with Chronic Obstructive Pulmonary Disorder (COPD) with three quarters of them living in low and middle-income countries. Therefore, as respiratory diseases often lead to complications such as asthma and COPD, there is an increased necessity for sophisticated catheterization techniques, for their diagnosis and treatment. Therefore, owing to this, the demand for deflectable catheters is expected to increase in the coming years owing to their crucial role in such procedures, thereby escalating the overall market of deflectable catheters during the given forecast period from 2024-2030.

However, the availability of alternative technologies such as hydraulic chambers, electrical energy, thermal energy, and magnets, among others may limit their end-user base, thus acting as key constraints limiting the growth of the deflectable catheter devices market.

Deflectable Catheters Segment Analysis:

Deflectable Catheters by Product Type (Uni-Directional Deflectable Catheters, Bi-Directional Deflectable Catheters, and Multi-Directional Deflectable Catheters), Application (Cardiology [Electrophysiology, Coronary Interventions, and Diagnostic Imaging], Pulmonology [Pulmonary Angiography, and Bronchography]), End-User (Hospitals & Clinics, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product type segment of deflectable catheters, the bi-directional deflectable catheter category is estimated to amass a significant revenue share in the deflectable catheters market in 2023. This can be attributed to the various advantages and applications provided by bi-directional catheters. Bi-directional catheters are easier to manipulate and control during medical procedures, as these catheters can bend in two directions, allowing more precise traverse through intricate anatomical systems. Bi-directional catheters allow focused energy supply to particular regions of heart tissue during cardiac interventions such as cardiac ablation, which treats arrhythmias.

Bi-directional deflectable catheters present notable benefits in managing cardiovascular and respiratory conditions owing to their minimal invasiveness and improved maneuvering capabilities. They enable precise maneuvering through intricate anatomical pathways, facilitating targeted treatments with less damage to adjacent tissues.

Additionally, several global manufacturers specialized in the production of Bi-Directional deflectable catheters, offering innovative solutions for various medical procedures are also playing a major role in boosting the market of deflectable catheters. For example, Bi-Directional Deflectable Catheters offered by Medtronic are renowned for their reliability and performance, which enables precise navigation within the body, making them suitable for a wide range of procedures including cardiac ablation and electrophysiology studies. Thus, global manufacturers play a pivotal role in advancing medical technology and improving patient care by offering innovative bi-directional deflectable catheters.

Therefore, the various advantages and applications provided by bi-directional deflectable catheters will contribute to the growth of this category, thereby driving the growth of the overall deflectable catheters during the forecast period.

North America Is Expected To Dominate The Overall Deflectable Catheters:

North America is expected to account for the highest proportion of the deflectable catheters market in 2023, out of all regions. This is due to the large patient pool suffering from cardiovascular disorders such as heart attacks & coronary artery diseases (CAD), respiratory disorders such as COPD, along with their associated risk factors in the US. Furthermore, the use of modern medical equipment encouraged by powerful regulatory frameworks in the region is expected to drive the market for deflectable catheters in North America during the forecast period.

According to the data provided by the Centers for Disease Control and Prevention (CDC) (2024), it was stated that 805,000 people in the US on an average have a heart attack every year, with 1 out of 5 being silent heart attacks. Additionally, as per the latest data provided by the National Institute of Health (2023), it stated that 20.5 million people in the US were living with CAD. Since deflectable catheters are essential in interventional cardiology procedures, such as angioplasty and stent placement for navigating complex vascular pathways and improve patient outcomes, their demand is expected to increase among cardiac patients in the upcoming years.

Therefore, the rising number of heart attack cases, and the growing cases of CAD highlight the critical role of deflectable catheters in cardiovascular care, as these devices facilitate a range of essential procedures that improve diagnosis, treatment, and patient outcomes in individuals suffering from serious cardiovascular conditions, thereby boosting the market of deflectable catheters.

According to data from the American Lung Association (2024), in 2023, it was stated that approximately 11.7 million people in the US were living with chronic respiratory disorders, which over time makes it harder for patients to breathe. Furthermore, as per the data provided by CDC (2023), in 2021, around 14.2 million people in the US had Chronic Obstructive Pulmonary Disease.

Considering the presence of a large patient pool suffering from respiratory disorders, the demand for deflectable catheters is expected to increase as they are crucial for bronchoscopy and other pulmonary interventions. Deflectable catheters allow precise navigation and access to the bronchial passages, aiding in the diagnosis and treatment of respiratory conditions and improving patient care amidst the growing respiratory disease burden.

Thus, the rising cases of cardiovascular and respiratory disorders in the US are key factors driving the growth of the deflectable catheters market in North America, that will eventually drive the overall market for deflectable catheters in North America during the forecast period.

Deflectable Catheters Key Players:

Some of the key market players operating in the Deflectable Catheters market include

Medtronic, Stryker, Cook, Integer Holdings Corporation, Abbott, Johnson & Johnson Services, Inc., BIOTRONIK SE & Co KG, Boston Scientific Corporation, Tiger Medical, Dynaflex, Medical Murray, Teleflex Incorporated, DuPont, Merit Medical Systems, jMedtech Coating Technologies Pte Ltd., and others.

Recent Developmental Activities In The Deflectable Catheters:

In March 2021, Medtronic announced CE mark approval for the SelectSite C304-HIS deflectable catheter system, as well as CE mark labeling expansion for the SelectSecure MRI SureScan Model 3830 cardiac pacing lead for use in His-bundle pacing procedures. A deflectable, out-of-plane curve on the SelectSite C304-HIS deflectable catheter system is intended to access the bundle of his in heart.

In January 2020, The FDA gave clearance to BioCardia, Inc.'s Morph DNA deflectable guide catheter for use in guiding the Helix biotherapeutic delivery system during the delivery of CardiAMP cell therapy in the heart. The purpose of Morph DNA is to improve the procedural control of therapeutic catheters, such the Helix system, when cell therapy is being delivered.

Key Takeaways From The Deflectable Catheters Report Study

Market size analysis for current deflectable catheters size (2023), and market forecast for 6 years (2024-2030)

Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years

Key companies dominating the global deflectable catheters.

Various opportunities are available for the other competitors in the deflectable catheter space.

What are the top-performing segments in 2023? How these segments will perform in 2030?

Which are the top-performing regions and countries in the current deflectable catheters scenario?

Which are the regions and countries where companies should have concentrated on opportunities for deflectable catheters growth in the coming future?

Target Audience Who Can Be Benefited From This Deflectable Catheter Report Study

Deflectable catheter product providers

Research organizations and consulting companies

Deflectable catheter-related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing in deflectable catheters

Various end-users who want to know more about deflectable catheters and the latest technological developments in deflectable catheters.

Frequently Asked Questions For The Deflectable Catheters:

1. What are deflectable catheters?

Deflectable catheters, also referred to as steerable or navigable catheters, are specialized medical instruments engineered for precise maneuverability within the body. These catheters have tips that can be actively controlled and adjusted in various directions, enabling them to navigate complex anatomical pathways and reach specific target areas.

2. What is the market for deflectable catheters?

The deflectable catheters market is estimated to grow at a CAGR of 5.14% during the forecast period from 2024 to 2030.

3. What are the drivers for the global deflectable catheters?

The demand for deflectable catheters is expected to increase primarily owing to the increasing cases of chronic disorders such as cardiovascular diseases including heart attack, atrial fibrillation, coronary artery disease; respiratory disorders like asthma, chronic obstructive pulmonary disease COPD, among others. Additionally, the rising shift towards minimally invasive approaches among healthcare professionals and patients is also expected to drive the market for deflectable catheters during the forecast period from 2024 to 2030.

4. Who are the key players operating in the global deflectable catheters?

Some of the key market players operating in the deflectable catheter include

Medtronic, Stryker, Cook, Integer Holdings Corporation, Abbott, Johnson & Johnson Services, Inc., BIOTRONIK SE & Co KG, Boston Scientific Corporation, Tiger Medical, Dynaflex, Medical Murray, Teleflex Incorporated, DuPont, Merit Medical Systems, jMedtech Coating Technologies Pte Ltd., and others.

5. Which region has the highest share in the global deflectable catheters?

North America is expected to dominate the overall deflectable catheters during the forecast period from 2024 to 2030. This is due to a large patient pool suffering from cardiovascular disorders such as heart attacks & coronary artery diseases (CAD), and respiratory disorders such as COPD with associated risk factors in the US. Furthermore, the use of modern medical equipment encouraged by powerful regulatory frameworks in the region is expected to drive the market for deflectable catheters during the forecast period.